393 related articles for article (PubMed ID: 26842469)
21. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
[TBL] [Abstract][Full Text] [Related]
22. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.
de Oliveira MF; Gianella S; Letendre S; Scheffler K; Kosakovsky Pond SL; Smith DM; Strain M; Ellis RJ
PLoS One; 2015; 10(10):e0139510. PubMed ID: 26431315
[TBL] [Abstract][Full Text] [Related]
23. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract.
Gianella S; Morris SR; Anderson C; Spina CA; Vargas MV; Young JA; Richman DD; Little SJ; Smith DM
AIDS; 2013 Jan; 27(1):39-47. PubMed ID: 22739399
[TBL] [Abstract][Full Text] [Related]
24. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
Gianella S; Chaillon A; Mutlu EA; Engen PA; Voigt RM; Keshavarzian A; Losurdo J; Chakradeo P; Lada SM; Nakazawa M; Landay AL
AIDS; 2017 Sep; 31(15):2059-2067. PubMed ID: 28906277
[TBL] [Abstract][Full Text] [Related]
25. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
26. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.
de França TR; de Albuquerque Tavares Carvalho A; Gomes VB; Gueiros LA; Porter SR; Leao JC
Clin Oral Investig; 2012 Apr; 16(2):659-64. PubMed ID: 22186943
[TBL] [Abstract][Full Text] [Related]
27. Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
Zanchetta M; Walker S; Burighel N; Bellanova D; Rampon O; Giaquinto C; De Rossi A
J Infect Dis; 2006 Jun; 193(12):1718-27. PubMed ID: 16703516
[TBL] [Abstract][Full Text] [Related]
28. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
30. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
31. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
32. Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
Hunt PW; Martin JN; Sinclair E; Epling L; Teague J; Jacobson MA; Tracy RP; Corey L; Deeks SG
J Infect Dis; 2011 May; 203(10):1474-83. PubMed ID: 21502083
[TBL] [Abstract][Full Text] [Related]
33. Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation.
Lupia T; Milia MG; Atzori C; Gianella S; Audagnotto S; Imperiale D; Mighetto L; Pirriatore V; Gregori G; Lipani F; Ghisetti V; Bonora S; Di Perri G; Calcagno A
AIDS; 2020 Mar; 34(3):373-380. PubMed ID: 31764071
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
35. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.
Stevens SJ; Blank BS; Smits PH; Meenhorst PL; Middeldorp JM
AIDS; 2002 May; 16(7):993-1001. PubMed ID: 11953465
[TBL] [Abstract][Full Text] [Related]
36. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
[TBL] [Abstract][Full Text] [Related]
37. Association Between Cytomegalovirus and Epstein-Barr Virus Viremia And Human Immunodeficiency Virus DNA Levels in the Reservoir of Kenyan Infants Receiving Antiretroviral Therapy.
Slyker JA; Guthrie B; Pankau M; Tapia K; Wamalwa D; Benki-Nugent S; Ngugi E; Huang ML; Njuguna I; Langat A; John-Stewart G; Lehman D
J Infect Dis; 2021 Jun; 223(11):1923-1927. PubMed ID: 33064809
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
39. High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis.
Pischke S; Gösling J; Engelmann I; Schlue J; Wölk B; Jäckel E; Meyer-Heithuis C; Lehmann U; Strassburg CP; Barg-Hock H; Becker T; Manns MP; Schulz T; Wedemeyer H; Heim A
J Hepatol; 2012 May; 56(5):1063-1069. PubMed ID: 22245897
[TBL] [Abstract][Full Text] [Related]
40. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
Buzon MJ; Martin-Gayo E; Pereyra F; Ouyang Z; Sun H; Li JZ; Piovoso M; Shaw A; Dalmau J; Zangger N; Martinez-Picado J; Zurakowski R; Yu XG; Telenti A; Walker BD; Rosenberg ES; Lichterfeld M
J Virol; 2014 Sep; 88(17):10056-65. PubMed ID: 24965451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
